Trump-Linked Fund Put $30 Million Into Airport Spa Company That Then Won Nearly $40 Million in Ebola Contracts, per ProPublica

From Airport Spas to Ebola Response

A fund tied to Donald Trump Jr. and Eric Trump put about $30 million into a cash-strapped airport spa company. Months later, the Trump administration awarded the company nearly $40 million in federal contracts to fight Ebola, per ProPublica.

The company, XWELL, made most of its money from airport spas and waxing salons, and had never worked on Ebola or overseas.

The fund, American Ventures, was launched by Dominari Holdings, a financial firm with offices in Trump Tower. Donald Trump Jr. and Eric Trump are advisers to Dominari and hold a stake in it, per ProPublica.

The Two Awards

XWELL's testing unit, XpresTest, won an $18.8 million CDC contract in June to screen airport travelers for Ebola.

It then won a $20 million State Department award in September for outbreak response in Congo.

"This is a risky contract. I'm not sure we can do it," the unit's CEO told ProPublica.

The State Department said its award came through a competitive process, per reporting on the story.

Do you want to see how to make more plays? Do you want to find gains yourself? Unusual Whales helps you find market opportunities through our market tide, historical options flow, GEX, and much, much more. Create a free account here to start conquering the market with Unusual Whales

The Response

A spokesperson for the Trump sons said they are "merely passive, minority investors" in the fund and had no knowledge of the contracts.

Nothing in the reporting shows either brother had a role in the contract awards.

ProPublica also reported that XWELL did not publicly announce either award, and that the contracts are not guaranteed money, since federal awards can be scaled back or terminated.

Options and Market Impact

XWEL is a microcap name, and headlines like this can produce outsized moves on thin volume, in both directions. Watch XWEL for unusual options activity and dark pool prints, and treat any spike with caution: the stock was close to bankruptcy before the February investment, per ProPublica, and the contracts now face public and political scrutiny.

Bottom Line

Per ProPublica, a Trump-linked fund's $30 million lifeline to XWELL was followed within months by nearly $40 million in federal Ebola contracts for a company with no Ebola track record, and the Trump sons say they were passive investors with no knowledge of the deals.

Sign up for Unusual Whales at https://unusualwhales.com/login?ref=blubber to track the flow on this story and the rest of the market.

Track XWEL on Unusual Whales
Unusual Whales does not confirm the information's truthfulness or accuracy of the associated references, data, and cannot verify any of the information. Any content on this site or related pages are not intended to provide legal, tax, investment or insurance advice. Unusual Whales Inc. is not registered as a securities broker-dealer or an investment adviser with the U.S. Securities and Exchange Commission, the Financial Industry Regulatory Authority (“FINRA”) or any state securities regulatory authority. Nothing on Unusual Whales should be construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security by Unusual Whales or any third party. Options, investing, trading is risky, and losses are more expected than profits. Please do own research before investing. Please only subscribe after reading our full terms and understanding options and the market, and the inherent risks of trading. It is highly recommended not to trade on this, or any, information from Unusual Whales. Markets are risky, and you will likely lose some or all of your capital. Please check our terms for full details.
Any content on this site or related pages are not intended to provide legal, tax, investment or insurance advice. Unusual Whales Inc. is not registered as a securities broker-dealer or an investment adviser with the U.S. Securities and Exchange Commission, the Financial Industry Regulatory Authority (“FINRA”) or any state securities regulatory authority. Nothing on Unusual Whales should be construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security by Unusual Whales or any third party. Certain investment planning tools available on Unusual Whales may provide general investment education based on your input. You are solely responsible for determining whether any investment, investment strategy, security or related transaction is appropriate for you based on your personal investment objectives, financial circumstances and risk tolerance. You should consult your legal or tax professional regarding your specific situation. See terms for more information.